merit medical systems, inc. (nasdaq: mmsi) is a leading manufacturer of medical devices used in diagnostic & interventional cardiology & radiology procedures. its primary products consist of inflation devices used in angioplasty, stent placement & discography; diagnostic & therapeutic catheters used for various procedures in cardiology & radiology; guide wires used to place balloon angioplasty catheters within a patient's coronary arteries; products used to manage & monitor the administration of contrast & other fluid solutions during diagnostic & therapeutic procedures; thrombolytic catheters & fluid dispensing systems; angiography accessories; & standard & custom angiography kits. headquartered in south jordan, utah, a suburb of salt lake city, merit employs approximately 1,900 people worldwide. merit markets its products in the united states & europe (direct sales force) & the world (distributors). they call directly on physicians & clinicians in hospitals & clinics worldwide. the c
![Merit Medical Systems logo](/files/LOGO/856982-MMSI.png)
Company profile
Ticker
MMSI
Exchange
Website
CEO
Fred Lampropoulos
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Merit Medical Australia Pty Ltd. • ITL Healthcare Pty Ltd. • Merit Medical Austria GmbH • Merit Medical Canada Ltd. • Merit Medical Colombia S.A.S. • Merit Medical Beijing Co. Ltd. • BioSphere Medical Japan, Inc. • BioSphere Medical, Inc. • Brightwater Medical, Inc. • BSMD Ventures, Inc. ...
IRS number
870447695
MMSI stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
1 Jul 24
SD
Conflict minerals disclosure
31 May 24
8-K
Merit Medical Shareholders Elect Silvia M. Perez as New Director
21 May 24
8-K
Merit Medical Executive Leadership Team Update
16 May 24
10-Q
2024 Q1
Quarterly report
30 Apr 24
8-K
Results of Operations and Financial Condition
30 Apr 24
ARS
2023 FY
Annual report to shareholders
2 Apr 24
DEFA14A
Additional proxy soliciting materials
2 Apr 24
DEF 14A
Definitive proxy
2 Apr 24
10-K
2023 FY
Annual report
28 Feb 24
Transcripts
MMSI
Earnings call transcript
2024 Q1
30 Apr 24
MMSI
Earnings call transcript
2023 Q4
28 Feb 24
MMSI
Earnings call transcript
2023 Q3
26 Oct 23
MMSI
Earnings call transcript
2023 Q2
25 Jul 23
MMSI
Earnings call transcript
2023 Q1
26 Apr 23
MMSI
Earnings call transcript
2022 Q4
22 Feb 23
MMSI
Earnings call transcript
2022 Q3
27 Oct 22
MMSI
Earnings call transcript
2022 Q2
28 Jul 22
MMSI
Earnings call transcript
2022 Q1
28 Apr 22
MMSI
Earnings call transcript
2021 Q4
26 Feb 22
Latest ownership filings
4
F. Ann Millner
2 Jul 24
144
Notice of proposed sale of securities
28 Jun 24
11-K
Annual report of employee stock purchases
28 Jun 24
4
Neil Peterson
12 Jun 24
144
Notice of proposed sale of securities
10 Jun 24
4
MICHAEL R MCDONNELL
20 May 24
4
Stephen C. Evans
20 May 24
4
Lonny J Carpenter
20 May 24
4
Thomas James Gunderson
20 May 24
4
David Floyd
20 May 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 583.99 mm | 583.99 mm | 583.99 mm | 583.99 mm | 583.99 mm | 583.99 mm |
Cash burn (monthly) | 1.72 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 6.65 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 577.34 mm | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 335.9 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2024
99.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 291 |
Opened positions | 262 |
Closed positions | 6 |
Increased positions | 15 |
Reduced positions | 6 |
13F shares | Current |
---|---|
Total value | 4.07 tn |
Total shares | 57.60 mm |
Total puts | 182.80 k |
Total calls | 890.48 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 9.51 mm | $720.15 bn |
Vanguard | 6.82 mm | $516.95 bn |
William Blair Investment Management | 3.04 mm | $230.50 bn |
STT State Street | 2.24 mm | $169.84 bn |
ArrowMark Colorado | 2.19 mm | $165.53 bn |
Conestoga Capital Advisors | 2.17 mm | $164.72 bn |
Fuller & Thaler Asset Management | 1.46 mm | $110.55 bn |
Dimensional Fund Advisors | 1.32 mm | $99.96 bn |
Geode Capital Management | 1.29 mm | $97.93 bn |
MCQEF Macquarie | 1.25 mm | $94.49 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Jun 24 | Millner F. Ann | Common Stock, No Par Value | Sell | Dispose S | No | Yes | 85 | 201 | 17.09 k | 32,391 |
28 Jun 24 | Millner F. Ann | Common Stock, No Par Value | Sell | Dispose S | No | Yes | 85 | 12,299 | 1.05 mm | 32,592 |
28 Jun 24 | Millner F. Ann | Common Stock, No Par Value | Option exercise | Acquire M | No | Yes | 50.5 | 12,500 | 631.25 k | 44,891 |
28 Jun 24 | Millner F. Ann | NQSO Common Stock | Option exercise | Dispose M | No | Yes | 50.5 | 12,500 | 631.25 k | 12,500 |
10 Jun 24 | Neil Peterson | Common Stock, No Par Value | Sell | Dispose S | No | Yes | 81.846 | 7,500 | 613.85 k | 14,819 |
10 Jun 24 | Neil Peterson | Common Stock, No Par Value | Option exercise | Acquire M | No | Yes | 44.8 | 7,500 | 336.00 k | 22,319 |
10 Jun 24 | Neil Peterson | NQSO Common Stock | Option exercise | Dispose M | No | Yes | 44.8 | 7,500 | 336.00 k | 0 |
16 May 24 | Laura S. Kaiser | Common Stock, No Par Value | Grant | Acquire A | No | No | 0 | 2,431 | 0.00 | 7,743 |
16 May 24 | Ward Lynne | Common Stock, No Par Value | Grant | Acquire A | No | No | 0 | 2,431 | 0.00 | 10,657 |
16 May 24 | Silvia Perez | Common Stock, No Par Value | Grant | Acquire A | No | No | 0 | 2,431 | 0.00 | 2,431 |
News
What 9 Analyst Ratings Have To Say About Merit Medical Systems
16 Jul 24
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $100 Price Target
16 Jul 24
Peering Into Merit Medical Systems's Recent Short Interest
19 Jun 24
Jim Cramer Offers His Take On Corning, Calls This Healthcare Stock A 'Terrific Spec'
23 May 24
Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $102
1 May 24
Press releases
Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
18 Jun 24
Merit Medical Launches basixSKY™ Inflation Device
21 May 24
Merit Medical Shareholders Elect Silvia M. Perez as New Director
16 May 24
Merit Medical Executive Leadership Team Update
15 May 24
Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe
14 May 24